Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
14.14%
End price
28.02.25
€173.50
Summary
This prediction ended on 28.02.25 with a price of €173.50. The prediction had a final performance of 14.14%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -5.188% | -5.188% | 31.921% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten